The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
MyMD Pharmaceuticals, Inc. announced a rebranding to the new name “TNF Pharmaceuticals, Inc.”. The company’s common stock, listed on the Nasdaq ...
read more
Donaldson, a provider of biomanufacturing technologies, with its Univercells Technologies business, announces that the Gene Therapy Program at the ...
read more
Johnson & Johnson announced that it has successfully completed the acquisition of Yellow Jersey, a demerged subsidiary of Numab Therapeutics to secure...
read more
SCG Cell Therapy Pte Ltd announced that the FDA approved the Investigational New Drug (IND) application to initiate Phase 1/2 clinical trial for ...
read more
The peptide synthesis market is poised for notable expansion in the foreseeable future. This process holds immense importance in the realm of ...
read more
ProBio Inc, a New Jersey-based contract development and manufacturing organization (CDMO), proudly announce the expansion of its plasmid DNA and viral...
read more
Today, the US FDA expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular ...
read more
The Celonic Group, a Swiss Based Quality Biologics Contract Development and Manufacturing Organization (CDMO) opened its “Next Generation” Biologics ...
read more
Macomics Ltd, a leader in macrophage drug discovery has announced the appointment of Simon Dew in the newly created position of Chief Business Officer...
read more
Bristol Myers Squibb announced that the FDA granted approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen ...
read more
Charles River Laboratories International, Inc. announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer ...
read more
Multiply Labs and Portal Biotechnologies announced their collaboration which combines the efficiency of Multiply Labs’ robotic automation with the ...
read more
Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs, and Retro Biosciences (Retro), a ...
read more
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene ...
read more
Takeda and AC Immune SA announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of...
read more